12:40 AM EST, 11/03/2026 (MT Newswires) -- Valbiotis (ALVAL.PA) delivered the first ValbiotisPRO products to its Chinese joint venture, Hangzhou Valbiotis Life Health Technology, for potential sales to Chinese consumers by the end of 2026. As the exclusive supplier to the 49%-owned joint venture, the French dietary supplements company will ship a total of 50,000 units of Cholestérol, Santé métabolique, Cardio-circulation, and Foie across two orders, according to a Monday release. Delivery of the second order, which is in production, is expected in the coming weeks. The venture, which is 51% owned by Aika, is also planning expansion in Hong Kong and Singapore.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.